title: Is frailty associated with cardiovascular drug use?
authors.forename: Teresa
authors.initials: T
authors.lastname: Pozos-López
authors.forename: Ana Patricia
authors.initials: AP
authors.lastname: Navarrete-Reyes
authors.forename: José Alberto
authors.initials: JA
authors.lastname: Ávila-Funes
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000009:adverse effects / Q000627:therapeutic use; D002317:Cardiovascular Agents / Q000009:adverse effects* / Q000627:therapeutic use*; D015331:Cohort Studies; D005260:Female; D016330:Frail Elderly; D006306:Health Surveys; D006801:Humans; D008297:Male; D008800:Mexico; D012307:Risk Factors; D055948:Sarcopenia / Q000139:chemically induced* / Q000453:epidemiology* / Q000517:prevention & control*
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D002317:Cardiovascular Agents